Loading...
01/10 16:12
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call indicates strong financial performance with improved margins, optimistic guidance, and double-digit growth in key areas like Test & Measurement and software ACV. Despite some uncertainties in discrete automation and sustainability projects, the company's strategic initiatives, regional growth expectations, and significant share repurchase plans suggest a positive outlook. The Q&A section highlights management's confidence in overcoming challenges, further supporting a positive sentiment.
Underlying orders growth 6% in the fourth quarter, driven by sustained demand in growth verticals and accelerating orders growth in Test & Measurement up 27%. Reasons include resilient demand and investments in automation technologies.
Underlying sales growth (Q4) 4%, with strong execution and adjusted segment EBITDA margin of 27.5% (up 1.3 points).
Adjusted earnings per share (Q4) $1.62, at the top end of guidance.
Full-year underlying sales growth 3%, slightly below expectations due to softer demand in Europe and China.
Adjusted earnings per share (Full Year) $6, up 9% year-over-year. Reasons include strong profitability and operational execution.
Free cash flow (Full Year) $3.24 billion, up 12% year-over-year, driven by higher earnings and improved working capital efficiency.
Annual contract value of software Grew 10% year-over-year, ending at $1.56 billion.
Gross profit margin 52.8%, an annual record.
Adjusted segment EBITDA margin 27.6%, an annual record, up 160 basis points year-over-year. Reasons include strong price cost, higher mix of software, and cost reductions.
Test & Measurement orders growth (Q4) 27%, with robust growth in all regions, led by semiconductor, aerospace, and defense.
LNG, power, and life sciences sales growth 11% year-over-year, driven by significant global investments.
MRO sales contribution 65% of total sales.
Synergies from AspenTech integration $50 million realized in 2025, with a plan to achieve $100 million by the end of 2026.
Free cash flow margin 18%, up 140 basis points from the prior year.
Ovation 4.0 Distributed Control System: Selected by Entergy to automate 3 additional power generation facilities, providing approximately 3.1 gigawatts of generation capacity. Also chosen to replace the existing excitation system at the Doel nuclear power station in Belgium, ensuring safe and clean baseload power.
DeltaV Control Systems & Software: Chosen for automation in 3 manufacturing facilities in Indianapolis by a U.S.-based life science customer. This will enhance production performance, regulatory compliance, and accelerate time to market for weight management drugs.
AI-powered applications: Launched Guardian Virtual Adviser for DeltaV life cycle management software and AspenTech's subsurface intelligence platform. These solutions enhance productivity, optimize system performance, and improve seismic interpretation workflows.
Test & Measurement: Orders grew 27% in Q4, driven by semiconductor, aerospace, and defense sectors. Broad-based growth across all regions.
Power sector: Momentum continues with Ovation orders up 18% in Q4 and 30% for the year, driven by greenfield projects and modernization.
LNG sector: Significant investment globally, including automation for the Woodside Louisiana LNG project, which can produce 16.5 million tons per annum with expansion capacity up to 27.6 million tons per annum.
Life sciences: Growth driven by greenfield projects and capacity expansions to meet demand for biologics and GLP-1s.
Adjusted segment EBITDA margin: Achieved 27.6% for 2025, exceeding expectations and up 160 basis points year-over-year due to cost reductions, synergies, and favorable software contract renewals.
Free cash flow: Generated $3.24 billion in 2025, up 12% year-over-year, driven by higher earnings and improved working capital efficiency.
Synergy realization: Achieved $50 million in synergies from AspenTech in 2025, with plans to reach $100 million by 2026, two years ahead of schedule.
Capital allocation: Plan to return $2.2 billion to shareholders in 2026, including $1 billion in share repurchases and $1.2 billion in dividends, marking a 5% dividend increase.
Regional growth focus: Strong growth expected in the Americas, India, and the Middle East and Africa, while Europe and China remain weak.
Portfolio transformation: Completed transformation with focus on automation leadership, aligning with secular trends in power, LNG, life sciences, and semiconductors.
Soft demand in Europe and China: Demand in Europe and China continues to be soft, which could impact overall sales growth and market performance in these regions.
Lingering weakness in automotive and factory automation: Discrete businesses, including automotive and factory automation, experienced lingering weakness, representing a headwind to sales growth.
Impact of tariffs: Tariffs negatively impacted gross profit by 20 basis points, adding cost pressures to operations.
Software contract renewal dynamics: A lower value of software contracts up for renewal in 2026 is expected to reduce sales growth and adjusted segment EBITDA margin, creating a temporary headwind.
Economic uncertainties in Europe and China: Muted demand in Europe and China reflects broader economic uncertainties, which could hinder growth in these key markets.
Integration challenges for acquisitions: While progress has been made in integrating AspenTech and Test & Measurement, achieving synergy targets ahead of schedule, integration challenges could still pose risks to operational efficiency.
Dependence on MRO sales: MRO sales represent 65% of total sales, indicating a heavy reliance on maintenance, repair, and operations, which could be vulnerable to economic downturns.
Regulatory compliance in life sciences: The need to ensure regulatory compliance in life sciences projects adds complexity and potential risks to execution.
Geopolitical risks in the Middle East and Africa: While the region is expected to grow, geopolitical risks could disrupt greenfield investments and overall market stability.
Fiscal 2026 Sales Growth: Guiding sales growth of 5.5% with underlying sales growth of approximately 4%, supported by sustained investment in growth verticals and robust performance in Test & Measurement.
Adjusted Segment EBITDA Margin: Expected to be approximately 28%, reflecting strong operational execution.
Adjusted Earnings Per Share: Guided to be between $6.35 and $6.55, reflecting strong operational execution.
Annual Contract Value (ACV): Projected to grow 10% plus as customers further invest to advance their digital transformation ambitions.
Capital Return to Shareholders: Plan to return approximately $2.2 billion, including $1 billion in share repurchases and $1.2 billion in dividends, with a 5% dividend per share increase.
Regional Sales Outlook: The Americas, India, and the Middle East and Africa are expected to remain strong drivers of growth in 2026, with muted demand in Europe and China.
Sector Growth Projections: Growth expected in power, LNG, life sciences, semiconductor, and aerospace and defense markets, which comprise approximately $6 billion of the $11.1 billion large project funnel.
Test & Measurement Segment: Planned to have high single-digit growth in both the first half and full year.
Control Systems & Software Segment: Expected to be down low single digits in the first half due to a $110 million headwind from a lower value of software contracts up for renewal in 2026.
Intelligent Devices Business Group: Projected to grow 3% in the first half and 4% for the full year, with sustained strength in MRO across core verticals.
Free Cash Flow: Expected to be $3.5 billion to $3.6 billion in 2026, representing approximately 10% growth.
Dividend Increase: Plan to raise the full-year dividend per share by $0.11 or approximately 5%, marking the 70th consecutive year of increasing dividends.
Debt Reduction: Plan to pay down approximately $1 billion of debt in 2026, aiming to end the year with a net debt to adjusted EBITDA ratio of approximately 2x.
Dividend Increase: In 2026, Emerson plans to raise its full-year dividend per share by $0.11, approximately a 5% increase. This marks the 70th consecutive year of increasing dividends, reflecting a long-standing commitment to shareholders.
Dividend Allocation: Emerson plans to allocate $1.2 billion to dividends in 2026.
Share Repurchase Program: Emerson intends to return approximately $1 billion to shareholders through share repurchases in 2026. The repurchases are planned to be ratable throughout the year.
The earnings call indicates strong financial performance with improved margins, optimistic guidance, and double-digit growth in key areas like Test & Measurement and software ACV. Despite some uncertainties in discrete automation and sustainability projects, the company's strategic initiatives, regional growth expectations, and significant share repurchase plans suggest a positive outlook. The Q&A section highlights management's confidence in overcoming challenges, further supporting a positive sentiment.
The earnings call presents a mixed outlook. Basic financial performance shows modest growth, with a 3% sales increase and stable margins despite tariffs. Product development is positive, with AspenTech synergies and new launches like Ovation AI. However, uncertainties in chemical markets and FX impacts on margins raise concerns. Market strategy indicates growth in Test & Measurement and power verticals, yet muted recovery in discrete automation. Shareholder returns are strong with $2.3 billion planned. Overall, the sentiment is balanced, with positive elements countered by market and margin challenges.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
